AskRx Tirzepatide Review: Cost, Brand-Only Access & Honest Verdict (2026)

AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications — no compounded drugs at all. Its LegitScript seal is independently confirmed genuine, served directly from LegitScript's own CDN. Every fact here comes from the company's own published program.

What AskRx is

AskRx is a telehealth platform, whose board-certified physicians trained in obesity medicine exclusively prescribe FDA-approved brand-name GLP-1 medications — no compounded products at all. Its LegitScript seal is independently verified served directly from LegitScript's own CDN, a genuine, real certification rather than a self-hosted image. It's as HIPAA compliant.

What AskRx costs

Tirzepatide (Zepbound/Mounjaro) is priced at $299/month for a 2.5mg dose, transparently published. AskRx doesn't dispense medication itself — fulfillment depends on third-party pharmacies, and medication cost is billed separately from the platform's own fee, per that same research. It serves all 50 states.

The brand-vs-compounded question

AskRx is one of the few providers in this ranking that offers brand-only access — no compounded copy at all. Brand tirzepatide (Zepbound, Mounjaro) is Eli Lilly's FDA-approved product, the exact molecule and dose studied in the pivotal trials. See our Zepbound cost and savings guide for the broader brand cash-price landscape.

How the care model holds up

AskRx's real strengths: only FDA-approved brand-name GLP-1s, no compounded products at all; a genuinely verified LegitScript seal; board-certified physicians trained in obesity medicine; transparent dose-based pricing published on the site; and coverage in all 50 states. The trade-offs: it's a cash-pay model with medication billed separately by the pharmacy; AskRx doesn't dispense medication itself, so fulfillment depends on third-party pharmacies; there's no compounded lower-cost alternative if brand pricing is out of reach; and the specific list of supported states isn't published beyond the general 50-state claim. As with any GLP-1 program, budget for the separate medication cost on top of the platform fee; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

AskRx is a strong pick if your priority is genuine brand-name tirzepatide from a platform with a real, verified LegitScript seal — and you accept there's no compounded fallback if the price is a stretch. If you want a lower-cost compounded option too, compare it against CoreAge Rx; if brand access with unlimited clinical contact matters more, weigh Synergy Rx. See our best tirzepatide providers ranking for the full field.